glp-1 drugs and parkinson's disease drug may help with disease, study reports Ozempic-Like Drug Failed to Treat

In 2021, the sales of Lilly's long-acting GLP-1 receptor agonist product dulaglutide were US$6.472 billion, up 49% from the previous year

placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial

The health effects of long-term use of these medications for weight loss are unknown and still in clinical trials

Why Plan Sponsors and Brokers Should Care About GLP-1s GLP-1s have been approved to treat diabetes and weight loss, and are showing promise in the treatment of other cardiometabolic diseases

Menopause [00:20:00] brain is something that a lot of women talk about when they experience the brain fog, the losing words, mid sentence, feeling like they, um, start a project, they can't follow through on the project 'cause their brain just runs outta steam